Navigation Links
Cancer screening: The efficacy of mammography screening
Date:12/3/2012

How effective is the German mammography screening program? This is the question examined by Oliver Heidinger of the Epidemiological Cancer Registry North RhineWestphalia and his co-authors in the first study on this subject in Germany, in Deutsches rzteblatt International (Dtsch Arztebl Int 2012; 109(46): 781-7).

To answer it, the authors have used the interval cancer rate as an indicator. Interval cancers are tumors found more or less by chance between two screenings. In approximately 880 000 women from North RhineWestphalia who had taken part in mammography screening for the first time between 2005 and 2008 and had received negative test results, the authors examined whether breast cancer occurred in the following 24 months. It was shown to occur in approximately 2000 women. This corresponds to a rate of 0.23%, a result that is absolutely comparable with similar international studies.

However, the authors also noticed another result in their follow-up research: 40% of all malignant breast tumors of size T2 to T4 (i.e. ranging from at least 2 cm to more than 5 cm) detected in the study participants during the observation period proved to be interval cancers. Further research is needed to explain this phenomenon.


'/>"/>

Contact: Oliver Heidinger
Oliver.Heidinger@krebsregister.nrw.de
Deutsches Aerzteblatt International
Source:Eurekalert

Page: 1

Related medicine news :

1. Clinical trial at GHSU Cancer Center targets advanced prostate cancer
2. New DNA-Based Blood Test May Spot Signs of Cancer
3. Aspirin May Reduce Risk of Liver Cancer, Death From Liver Disease
4. Johns Hopkins scientists pair blood test and gene sequencing to detect cancer
5. COUP-TFII sparks prostate cancer progression
6. Studies from 2012 Quality Care Symposium highlight findings in improving quality of cancer care
7. Researchers report first success of targeted therapy in most common non-small cell lung cancer
8. Scripps Florida scientists uncover a novel cooperative effort to stop cancer spread
9. Research from ASCOS Quality Care Symposium shows advances and challenges in improving the quality of cancer care
10. Scripps Research Institute study points to potential new therapies for cancer and other diseases
11. Study: Chest CT Scans May Increase Breast Cancer Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... March 23, 2017 , ... ChenMed, a privately ... completion of the strategic executive team expansion needed to further optimize growth and ... executive team,” says Christopher Chen, MD, ChenMed Chief Executive Officer. “George Wheeler ...
(Date:3/23/2017)... ... March 23, 2017 , ... Inflow IQ & Inflownomics of Raleigh, ... build on a solid foundation. As experts in dangerous situations the Inflow IQ ... coming soon. Inflownomics deliver ripe, fresh, clean & refreshing knowledge systems that enhance life. ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... Force Dagger Foundation the US Special Operations Command’s Patriot Award. The award was ... Thomas thanked Task Force Dagger Foundation for its significant and enduring support to ...
(Date:3/23/2017)... ... 23, 2017 , ... “Beyond and Back”: a true-life testimony of tragedy and ... published author Bonetta Rose, a wife, mother and grandmother committed to sharing her many ... Publishing, Bonetta Rose‘s new book presents actual events in the life of her family, ...
(Date:3/23/2017)... ... March 23, 2017 , ... “The Trainer”: an ... published author, Scotty, a fiction writer with an active imagination and an enthusiasm for ... book follows the tale of Wild Bill Hart, who sat looking at the thirty-three ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... , March 23, 2017 CENTRO DE ... article 157, paragraph 4 of Law 6,404/76 and Instruction ... hereby informs its shareholders and the market in general ... its subsidiary Centro de Diagnosticos por Imagem Ltda. (" ... 100% interest in RADIOLOGISTAS ASSOCIADOS LTDA. (" Partnership " ...
(Date:3/23/2017)... 2017 Ascendis Pharma A/S (Nasdaq: ASND), a ... address significant unmet medical needs in rare diseases, today ... and webcast on Monday, April 3 during ENDO 2017, ... Orlando, Florida , to discuss new data ... Hormone, TransCon PTH and TransCon CNP). Ascendis ...
(Date:3/23/2017)... - INVICTUS MD STRATEGIES CORP. ("Invictus MD" or the "Company") ... that AB Laboratories Inc. ("AB Labs") has successfully completed ... the Access to Cannabis for Medical Purposes Regulations ("ACMPR") ... The facility, which was licensed for Cultivation ... at half capacity, with full production capacity scheduled by ...
Breaking Medicine Technology: